OSL: OncoSil Medical Limited - Summary | Jitta

OncoSil Medical Limited

AUS:OSL

Price
AU$0.45
Loss Chance
58.3%
0.01JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
120 / 126
1,034 / 1,065
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (35)
Recent Business Performance (58)
Financial Strength (26)
Return to Shareholders (4)
Competitive Advantage (21)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.01
100.00%
2.66
158.11%
Life Sciences Tools and Services
4.16
98.58%
5.51
114.81%
2.80
100.00%
COMPANY DESCRIPTION
OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company’s lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.